PCR VS LATERAL FLOW IN BLOOD PARASITISM Sensitivity, subclinical infection, and the limits of diagnostics in real veterinary practice

Blood parasitism remains one of the most common yet diagnostically challenging conditions in small animal practice, particularly in endemic regions.

Clinicians frequently encounter:

  • Discordant test results
  • Subclinical infections
  • Chronic hematologic abnormalities without definitive confirmation

The increasing availability of PCR has led to the perception that it is the “gold standard.” However, this assumption must be interpreted in the context of parasite biology, host response, and real-world clinical limitations.

COMMON CANINE BLOOD PARASITES

In practice, the most relevant pathogens include:

  • Ehrlichiosis (Ehrlichia canis)
  • Anaplasmosis (Anaplasma spp.)
  • Babesiosis (Babesia spp.)
  • Hepatozoonosis (Hepatozoon spp.)

Each organism exhibits different:

  • Tissue tropism
  • Circulation patterns
  • Immune dynamics

These differences directly influence diagnostic outcomes.

WHAT ARE WE REALLY DETECTING?

A critical but often overlooked point:

– Most blood parasite lateral flow kits used in practice are antibody-based tests.

This is especially true for:

  • Ehrlichia
  • Anaplasma
  • Babesia

But not true for Dirofilaria immitis.

Meaning:

A positive rapid test = evidence of exposure and immune response
Not necessarily active infection

In contrast:

PCR detects parasite DNA, representing organism presence at the time of sampling

DIAGNOSTIC MODALITIES

Polymerase Chain Reaction (PCR)

Detects parasite nucleic acid (DNA) in blood.

Strengths:

  • High analytical sensitivity
  • Detects low parasitemia
  • Useful in early infection
  • Species-level identification

Limitations:

  • Requires circulating organisms
  • False negatives in low or intermittent parasitemia
  • Affected by sample quality and inhibitors
  • Higher cost and limited accessibility

Lateral Flow Assays (Rapid Test Kits)

Primarily detect:

  • Antibodies (Ehrlichia, Anaplasma, Babesia)
  • Occasionally antigens (Dirofilaria immitis)

Strengths:

  • Rapid results
  • Affordable
  • No specialized equipment
  • Suitable for routine clinical use

Limitations:

  • Lower sensitivity vs PCR
  • Antibody persistence after infection
  • Potential cross-reactivity

DISCORDANT RESULTS: UNDERSTANDING THE PATTERN

Lateral Flow Positive, PCR Negative

Common in ehrlichiosis.

Possible explanations:

  • Persistent antibodies after prior exposure
  • Subclinical or chronic infection
  • Organism sequestration
  • PCR sampling limitation

Lateral Flow Negative, PCR Positive

Seen in:

  • Early infection (pre-seroconversion)
  • Low parasite burden

PCR detects infection before immune response is measurable.

SUBCLINICAL AND SEQUESTERED INFECTION

In diseases such as Ehrlichia canis:

Acute phase → circulating organisms
Subclinical phase → reduced parasitemia
Chronic phase → localization in bone marrow and spleen

This reflects the concept of:

pathogen sequestration

Diagnostic Implications

  • PCR may be negative if organisms are not in peripheral blood
  • Antibody tests may remain positive despite low or controlled infection

Thus:

Negative PCR does not exclude infection
Positive antibody test does not confirm active disease

CLINICAL INTERPRETATION FRAMEWORK

Accurate diagnosis requires integration of:

1. Hematologic Findings

  • Thrombocytopenia
  • Anemia
  • Pancytopenia in chronic cases

2. Clinical Context

  • Tick exposure history
  • Endemic environment
  • Recurrence of signs

3. Diagnostic Trends

  • Serial CBC monitoring
  • Repeat testing when necessary

4. Therapeutic Response

In selected cases, response to treatment supports presumptive diagnosis.

PRACTICAL APPLICATION IN REAL-WORLD SETTINGS

In many veterinary practices:

  • PCR is not readily accessible
  • Cost limits routine use

Under these conditions:

Lateral flow assays serve as frontline screening tools
Clinical judgment becomes central to decision-making

DISCUSSION

PCR is often described as “superior” due to its analytical sensitivity.

However:

Sensitivity alone does not define clinical utility

Diagnostic accuracy depends on:

  • Stage of infection
  • Parasite distribution
  • Host immune response
  • Sampling limitations

No single test provides complete certainty across all disease phases.

CONCLUSION

PCR and lateral flow assays are complementary tools.

PCR excels in detecting low-level and early infections
Lateral flow tests provide rapid, accessible clinical guidance

In subclinical and chronic infections, both have limitations.

FINAL POINT

Blood parasitism is not diagnosed by a single test.

It is diagnosed through clinical reasoning supported by diagnostics

Not dictated by them.

REFERENCES

  • Harrus S, Waner T. Canine monocytic ehrlichiosis: pathogenesis and diagnosis
  • Neer TM. Ehrlichiosis: chronic phase and bone marrow involvement
  • Irwin PJ. Canine babesiosis: epidemiology and diagnosis
  • Otranto D et al. Vector-borne disease diagnostics in dogs
  • ESCCAP Guidelines: Control of vector-borne diseases
  • PLOS ONE: Limitations of PCR in low parasitemia infections

Dr. Geoff Carullo is a Fellow and the current President of the Philippine College of Canine Practitioners.

Sharing this helps others understand what it really means to be a vet. If you found this valuable, like and follow for more insights.

Advertisement

Share to your Network: